O 
26.84
+13.97%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Net income
−$105.7m
FY2021FY2025
Free cash flow
−$115.4m
FY2021FY2025
Shareholders' equity
$1.48bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross profit | −$522,000 | −$268,000 | −$75,000 | — | — |
| Research and development | $58.9m | $26.7m | $9.8m | $6.0m | $2.5m |
| Operating income | −$139.3m | −$52.8m | −$18.6m | −$10.0m | −$5.2m |
| Net income | −$105.7m | −$73.6m | −$32.2m | −$10.0m | −$5.2m |
| Diluted earnings per share | -0.72 | -0.53 | -0.46 | -0.16 | -0.08 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | $1.53bn | $281.7m | $14.9m | $11.0m | $11.0m |
| Cash and short-term investments | $1.23bn | $227.8m | $9.9m | $9.7m | $10.4m |
| Total liabilities | $52.2m | $30.9m | $49.2m | $39.1m | $4.7m |
| Debt | $904,000 | — | — | — | — |
| Shareholders' equity | $1.48bn | $250.9m | −$34.4m | −$28.1m | $6.3m |
| Shares outstanding | 146m | 138m | 69m | 64m | 64m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | −$82.2m | −$38.4m | −$16.0m | −$10.0m | −$1.9m |
| Capital spending | −$33.2m | −$352,000 | −$83,000 | −$149,560 | −$59,840 |
| Free cash flow | −$115.4m | −$38.7m | −$16.1m | −$10.1m | −$1.9m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2m | — | — | — | — | — | — | — |
| Gross profit | $489,000 | −$163,000 | −$149,000 | — | −$125,000 | −$124,000 | −$87,580 | −$68,747 |
| Operating income | −$73.2m | −$51.2m | −$57.1m | −$36.3m | −$28.0m | −$17.9m | −$15.4m | −$12.3m |
| Net income | −$48.5m | −$33.1m | −$41.4m | −$29.7m | −$24.7m | −$9.8m | −$10.3m | −$10.0m |
| Diluted earnings per share | -0.28 | -0.19 | -0.28 | -0.20 | -0.17 | -0.07 | -0.07 | -0.07 |
| Cash from operations | −$47.0m | −$17.0m | −$33.0m | −$18.0m | −$18.0m | −$12.0m | −$13.0m | −$7.0m |
| Capital spending | −$94.0m | −$32.0m | −$26.0m | −$5.0m | — | — | — | — |
| Free cash flow | −$141.0m | −$49.0m | −$59.0m | −$23.0m | — | — | — | — |
| Total assets | $3.36bn | $2.70bn | $1.53bn | $1.25bn | $731.1m | $302.1m | $281.7m | $293.8m |
| Cash and short-term investments | $1.64bn | $2.21bn | $1.23bn | $921.6m | $534.4m | $201.0m | $227.8m | $231.4m |
| Debt | $1.7m | $1.0m | $904,000 | $1.2m | $1.1m | $941,000 | $742,000 | $692,762 |
| Shareholders' equity | $3.27bn | $2.64bn | $1.48bn | $1.21bn | $696.4m | $269.3m | $250.9m | $263.3m |
Financial ratios
Data as of 5 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Return on equity | -7.2% | -29.3% | 93.6% | 35.7% | -81.9% |
| Return on assets | -6.9% | -26.1% | -216.1% | -91.2% | -46.7% |
| Free cash flow yield | -0.9% | -0.8% | -0.6% | -0.4% | -0.1% |
| Earnings growth | 43.5% | 128.8% | 221.0% | 94.4% | — |
| Current ratio | 49.08x | 43.47x | 4.43x | 16.54x | 23.91x |
| Debt to equity | 0.00x | 0.00x | -0.01x | -0.01x | 0.03x |
| Equity ratio | 96.6% | 89.0% | -230.8% | -255.8% | 57.1% |
| Interest coverage | — | — | — | -1.39x | -42.78x |
| Buybacks as a share of market value | -6.3% | -98.9% | -8.3% | 0.0% | -11.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | 140.4% | — | — |
| Net income | 119.3% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | -99.4 | -39.7 | -10.5 | -29.3 | -56.6 |
Market value over time
30 Jul 2021 to 2 Oct 2026, in USD
$137.9m$6.32bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Return | 323% | 273% | 8% | 1% | -2% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.